yuelan
Johnson & Johnson (JNJ) is in discussions to purchase Intra-Cellular Therapies (NASDAQ:ITCI).
A deal may happen as soon as this week, according to a Bloomberg report on Sunday, which cited people familiar with the matter.Talks are ongoing and a deal